Please login to the form below

23

Revenue 2017

Teva

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Teva's 2013 sales performance.

World At Their Feet: Brand Revitalisation Campaign

World At Their Feet: Brand Revitalisation Campaign. Therapy area: Central Nervous System. View the PMHub profile for: VCCP Health.

World At Their Feet: Press Advert

World At Their Feet: Press Advert. Therapy area: Central Nervous System. View the PMHub profile for: VCCP Health.

P&G agrees $4.2bn buy of Merck KGaA’s consumer health unit

portfolio”. The deal comes as P&G agreed to terminate its seven-year-old joint venture with Teva, which the two companies said was up for review in February.

Amgen and Novartis migraine drug hits the mark again

other CGRP drugs in development, a group which includes Eli Lilly's galcanezumab, Teva's fremanezumab and Alder's eptinezumab.

Result pages: 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 (Next 4)

Data provided by GlobalData

GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.

To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com

For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology

Featured jobs

Senior Account Manager – Med Comms – Kent: Salary TBC

Senior Medical Writer: Great salary and bebefits

Account Manager, Healthcare PR: £40, 000 – £42, 000 great benefits and bonuses

Editor – Medical Education Agency – Bucks: Salary TBC

Medical Writer - (London, Brighton or Copenhagen): Competitive

Editorial Director – Medical Education – Oxford: Negotiable

Engagement Strategist, Healthcare Brand Communications, London, ...: Circa £60K

HOME BASED Senior Account Executive / Account Manager - Medical ...: Salary TBC

Senior Medical Writer: Great salary and benefits

Editorial Team Leader or Scientific Director: £50, 000 - £55, 000 benefits

Senior Account Manager or AD - Medical Communications: Salary TBC

Senior Medical Writer, Medical Communications, Relocate to Cardi...: Excellent Salary

Digital Senior Account Director – Healthcare Advertising – Londo...: Salary TBC

Senior / Principal Regulatory Writer – Home Working - UK or US: HIGHLEY COMPETATIVE SALARY, BONUS &BENEFITS

Account Director - Global Healthcare Advertising (Digital) - Lon...: £55000 - £65000

Scientific Director: Great salary and bebefits

Account Manager – Med Comms – London: Salary TBC

Editor > Senior Editor – Medical Education – London: Very competitive with excellent benefits

Senior Account Manager / Account Director: Great salary and bebefits

Science writer, Healthcare Brand Communications, London, £45-50K...: £45-50K

FREELANCE Account Manager – Creative Healthcare Advertising – Lo...: SUPERB DAY RATES AVAILABLE

Head of Operations/ BUD, Healthcare PR, London – Excellent leade...: Excellent Package

Senior Programme Executive: Salary TBC

FREELANCE OPPORTUNITIES!!!!! Medical Education - Healthcare Adve...: EXCELLENT DAY RATES AVAILABLE

Principal Medical Writer, Medical Communications, Relocate to Ca...: Excellent Salary

Why heading online for scientific meetings can yield greater HCP engagement: Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance: Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies: Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...